Corcept presents survival data for Lifyorli in ovarian cancer at ASCO
Go back to Corcept presents survival data for Lifyorli in ovarian cancer at ASCO| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 79.91 -1.84 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $81.75 | 52 Week High | $10.00 | |||
| Open | $82.82 | 52 Week Low | $3.22 | |||
| Day High | $83.30 | P/E | N/A | |||
| Day Low | $79.40 | EPS | $-0.46 | |||
| Volume | 1,875,598 | |||||
